• Explore /
  • Poster
  • / Upfront vs deferred monoclonal antibodies in metastatic colorectal cancer: A target trial emulation using the GEMCAD 14-01 prospective cohort.

Upfront vs deferred monoclonal antibodies in metastatic colorectal cancer: A target trial emulation using the GEMCAD 14-01 prospective cohort.

Abstract Poster

Authors

null

Joan Maurel

Hospital Clínic Barcelona, Barcelona, Spain

Joan Maurel , Helena Oliveres , Vicente Alonso , Jaime Feliu , Ana Fernandez-Montes , Marta Martin-Richard , Elisa Galvez , Ana Ruiz-Casado , Alfonso Yubero-Esteban , Jorge Aparicio , Julia Alcaide , Javier Gallego , Alberto Carmona , Carlos Fernandez-Martos , Rosa Maria Gallego Sanchez , Hermini Manzano , Ruben Leno , Miriam Cuatrecasas , Xabier Garcia de Albeniz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

NCT02254941

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 3597)

DOI

10.1200/JCO.2023.41.16_suppl.3597

Abstract #

3597

Poster Bd #

297

Abstract Disclosures

Similar Posters

First Author: Tharani Krishnan

First Author: Ying Liu

First Author: Larissa Machado

First Author: Kimberly Lowe